Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 26, 2020 07:23 ET | Source: Research and Markets

Global Theranostics Markets Report 2020: Oncology Segment Market for Theranostics Should Grow from $73.1 Billion in 2020 to $119.7 Billion by 2025

Dublin, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The "Theranostics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for theranostics should grow from $80.4...
June 22, 2020 10:26 ET | Source: Allied Market Research

Uveitis Treatment Market to Reach $687.4 Mn, by 2026: AMR

Portland, OR, June 22, 2020 (GLOBE NEWSWIRE) -- According to the report, the global uveitis treatment market was pegged at $500.7 million in 2019 and is expected to reach $687.4 million by 2026,...
January 17, 2018 12:29 ET | Source: BCC Research

Global Cancer Stem Cell Market to Reach Nearly $2B by 2022

WELLESLEY, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Cancer stem cells have been found in a range of human tumors and are potential targets for cancer treatment. The global cancer stem cell...
December 11, 2017 15:27 ET | Source: VisionGate, Inc.

New Research Study Demonstrates Applicability of VisionGate’s 3-Dimensional Cell-CT™ Imaging and Analysis Platform

Seattle, WA, Dec. 11, 2017 (GLOBE NEWSWIRE) -- New research conducted by Arizona State University’s (ASU) Biodesign Institute and published in Science Advances (published by the American Association...
November 09, 2016 09:13 ET | Source: Admera Health, LLC

Admera Health Expands Oncology Test Portfolio with Launch of OncoGxSelect™ at the AMP 2016 Annual Meeting

SOUTH PLAINFIELD, N.J. and CHARLOTTE, N.C., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Molecular diagnostics company, Admera Health announced the official launch of OncoGxSelect™ while exhibiting at the...
January 28, 2013 08:30 ET | Source: MolecularMD

MolecularMD Corp. Obtains Exclusive License to LKB1 Uses in Non-Small Cell Lung Cancer

PORTLAND, OR--(Marketwire - Jan 28, 2013) - MolecularMD Corp. announced today that it has entered into a license agreement granting the company exclusive patent rights to cancer diagnosis...